Riskpilot← Back to searchSign inGet full accessSENTRUM FYSIOTERAPI VOSS AS
ASActiveOrg 920297455Sverresplassen 4, 5700 VossPhysiotherapy activities · NACE 8695Est. 20180 employees
Revenue 2025
NOK 346K
+9% vs 2024
EBITDA margin
0.6%
+109% vs 2024
Equity ratio
29.1%
Financial strength
Net profit 2025
NOK -3K
+88% vs 2024
| Revenue | NOK 346K | +9% |
| EBITDA | NOK 2K | +109% |
| Net profit | NOK -3K | +88% |
| Total assets | NOK 27K | -35% |
| Equity | NOK 8K | -30% |
| Employees | 0 | — |
Legal name
SENTRUM FYSIOTERAPI VOSS AS
Org number
920297455
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
24. januar 2018
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av gruppepraksis innan fysioterapi.
Address
Sverresplassen 4, 5700 Voss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 278 | 360 | 339 | 317 | 346 |
| Staff expenses | −10 | −5 | −2 | −1 | −7 |
| EBITDA | −41 | 7 | −1 | −22 | 2 |
| Depreciation & amort. | −6 | −9 | −9 | −7 | −5 |
| EBIT | −46 | −2 | −10 | −29 | −3 |
| Net financials | 0 | 0 | 0 | 0 | −0 |
| Profit before tax | −46 | −2 | −10 | −29 | −3 |
| Tax | 0 | −0 | −0 | −0 | −0 |
| Net profit | −46 | −2 | −10 | −29 | −3 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 107 | 60 | 68 | 41 | 27 |
| Equity | 52 | 51 | 40 | 11 | 8 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 55 | 10 | 28 | 29 | 19 |
| Total debt | 55 | 10 | 28 | 29 | 19 |
EBITDA margin
0.6%
This company
15.8%
Market median
-96% vs market
20212025
Equity ratio
29.1%
This company
38.2%
Market median
-24% vs market
20212025
Return on equity
-43.5%
This company
18.4%
Market median
-336% vs market
20212025
Net profit margin
-1.0%
This company
8.1%
Market median
-112% vs market
20212025
Asset turnover
13.01×
This company
1.12×
Market median
+1062% vs market
20212025
Debt / equity
2.43×
This company
0.62×
Market median
-292% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OJ Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2018 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20.83% | 20.83% | 2024 | |
| Individual | 20.83% | 20.83% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SENTRUM FYSIOTERAPI VOSS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Johnny Carlsen | Chief Executive Officer | 0 companies |
| Bjørn Ystaas | Board of Directors | 0 companies |